rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
12
|
pubmed:dateCreated |
1975-5-13
|
pubmed:abstractText |
Bumetanide is an effective diuretic for the treatment of ascites. Fifteen out of 17 patients with chronic liver disease responded satisfactorily and the incidence of hepatic encephalopathy and electrolyte disturbances was similar to that previously observed with frusemide. Colicky abdominal pain was reported in three patients but no other adverse effects were noted. An unexpected response was obtained in two patients who had diuresis without natriuresis.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0017-5749
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
988-92
|
pubmed:dateRevised |
2009-11-18
|
pubmed:meshHeading |
pubmed-meshheading:4448415-Adolescent,
pubmed-meshheading:4448415-Adult,
pubmed-meshheading:4448415-Aged,
pubmed-meshheading:4448415-Ascites,
pubmed-meshheading:4448415-Benzoates,
pubmed-meshheading:4448415-Bilirubin,
pubmed-meshheading:4448415-Blood Glucose,
pubmed-meshheading:4448415-Body Weight,
pubmed-meshheading:4448415-Butylamines,
pubmed-meshheading:4448415-Chronic Disease,
pubmed-meshheading:4448415-Diuretics,
pubmed-meshheading:4448415-Female,
pubmed-meshheading:4448415-Hepatic Encephalopathy,
pubmed-meshheading:4448415-Humans,
pubmed-meshheading:4448415-Liver Diseases,
pubmed-meshheading:4448415-Male,
pubmed-meshheading:4448415-Middle Aged,
pubmed-meshheading:4448415-Natriuresis,
pubmed-meshheading:4448415-Phenyl Ethers,
pubmed-meshheading:4448415-Potassium,
pubmed-meshheading:4448415-Sodium,
pubmed-meshheading:4448415-Sulfonamides,
pubmed-meshheading:4448415-Urea
|
pubmed:year |
1974
|
pubmed:articleTitle |
Use of bumetanide in the treatment of ascites due to liver disease.
|
pubmed:publicationType |
Journal Article
|